The JAK inhibitor deuruxolitinib has been approved by the MHRA as a treatment option for adults with severe alopecia areata.

Using CDK4/6 inhibitors as first-line therapy in advanced breast cancer does not improve overall survival compared with ...

The type of valved holding chamber used with inhaled salbutamol can significantly influence clinical outcomes in acute ...

Explore key takeaways from the inaugural EAPCI Summit highlighting how interventional cardiology is evolving beyond technical ...

Early prophylactic hydrocortisone for extremely preterm infants may increase BPD-free survival without raising rates of complications.

People living with vitiligo experience substantial levels of mood- and stress-related mental health disorders, according to a cohort study.

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.

Dupilumab reduces itch severity and overall disease activity in patients with refractory chronic spontaneous urticaria (CSU), according to the results of a recent trial supporting earlier findings ...

Dr Ari Manuel joins the Clinical Excellence in Respiratory Care speaker line-up to discuss complex ventilatory failure and OSA.

Psoriasis symptom and quality of life improvements occur rapidly with bimekizumab and remain durable for up to three years, study shows.

Starting full milk feeds from birth in preterm infants is associated with lower healthcare costs compared to gradual feeding with IV fluids.